CIK: 0001710065
Total reported value
—
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 78.18% | -84.07% | EXIT | |
| 2 | KYMR | Kymera Therapeutics INC | Stock-Other | 17.89% | -5.36% | EXIT | |
| 3 | SEER | Seer INC | Stock-Other | 1.84% | -5.06% | EXIT | |
| 4 | ✓ | Rallybio CORP | Stock-Other | 0.71% | — | — | |
| 5 | ✓ | Xilio Therapeutics INC | Stock-Other | 0.62% | — | — | |
| 6 | STRO | Sutro Biopharma, Inc. | Stock-Other | 0.31% | -1.43% | EXIT | |
| 7 | CARM | Carisma Therapeutics INC | Stock-Other | 0.29% | — | — | |
| 8 | ✓ | Rapt Therapeutics INC | Stock-Other | 0.15% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | — | NEW | New buy |
| 2 | KYMR | Kymera Therapeutics INC | — | NEW | New buy |
| 3 | SEER | Seer INC | — | NEW | New buy |
| 4 | ✓ | Rallybio CORP | — | NEW | New buy |
| 5 | ✓ | Xilio Therapeutics INC | — | NEW | New buy |
| 6 | STRO | Sutro Biopharma, Inc. | — | NEW | New buy |
| 7 | CARM | Carisma Therapeutics INC | — | NEW | New buy |
| 8 | ✓ | Rapt Therapeutics INC | — | NEW | New buy |